Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rahalison, L.
Right arrow Articles by Carniel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rahalison, L.
Right arrow Articles by Carniel, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2000) 45, 541-545
© 2000 The British Society for Antimicrobial Chemotherapy


Brief reports

Failure of oily chloramphenicol depot injection to treat plague in a murine model

Lila Rahalisona, Annie Guiyouleb, Stephane P. Bonacorsic, Ivan Slacanind, Suzanne Chanteaua and Elisabeth Carnielb,*

a Laboratoire de la Peste, Institut Pasteur de Madagascar, BP 1274 Antananarivo, Madagascar; b National Reference Laboratory and WHO Collaborating Center for Yersinia, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris Cedex 15; c Hôpital Robert Debré, Laboratoire de Bactériologie, 75019 Paris, France; d Laboratoire Central, Rue du Canal 1, 2502 Bienne, Switzerland

Effective low-cost single-dose therapy would be invaluable in treating human plague. The efficacy of single- or two-dose injections of oily chloramphenicol (OCm) was compared with that of standard multiple injections of reference drugs (streptomycin or chloramphenicol) in a murine plague model. A single injection of OCm was ineffective. Two doses cleared bacteraemia and limited bacterial growth in the mouse spleen but were less effective in reducing mortality than standard therapy. However, because of the marked pharmacokinetic differences between mice and humans, the failure of depot injection of OCm in murine plague treatment is not indicative of its ineffectiveness in human plague.

* Corresponding author. Tel: +33-1-45-68-83-26; Fax: +33-1-40-61-30-01; E-mail: carniel2{at}pasteur.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
E. Hernandez, M. Girardet, F. Ramisse, D. Vidal, and J.-D. Cavallo
Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents
J. Antimicrob. Chemother., December 1, 2003; 52(6): 1029 - 1031.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.